The NCRI Upper Gastrointestinal Group has four subgroups that develop research in areas of strategic need.
The hepatobiliary workstream, chaired by Mr Hassan Malik, develops research into cancer of the liver, bile ducts, and/or gallbladder.
Members:
Hassan Malik, Aintree University Hospital (subgroup chair)
Bristi Basu, Medical Oncologist, Academic Consultant in Experimental Cancer Therapeutics, University of Cambridge
Tom Bird, Honorary Consultant Hepatologist, University of Glasgow
John Bridgewater, Professor in medical oncology, UCL Cancer Institute
Saoirse Dolly, Clinical Fellow, Royal Marsden NHS Foundation Trust
Maria Hawkins, Professor in Radiation Oncology, University College London (UCL)
Matthew Hoare, Clinician Scientist & Honorary Consultant in Hepatology, Cancer Research UK (CRUK) Cambridge Institute
Timothy Kendall, Pathologist, University of Edinburgh
Andre Lopes, University College London (UCL)
Yuk Ting Ma, Clinical Lecturer, King’s College London (KCL)
Mairead Mcnamara, Honorary Consultant, Christie NHS Foundation Trust
Tim Meyer, Professor of Experimental Cancer Medicine, University College London (UCL)
Helen Morement, NCRI Consumer Forum member
Pam O’Donoghue, Lead GI Cancer Clinical Nurse Specialist, Harley Street Clinic
Daniel Palmer, University of Liverpool
Samir Pathak, Academic Clinical Lecturer/ Specialist registrar in HPB surgery, University Hospitals Bristol NHS Foundation Trust
John Primrose, Professor of Surgery, University of Southampton
Helen Reeves, King’s College London (KCL)
Paul Ross, Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust
Ian Rowe, Honorary Consultant Hepatologist, University of Leeds
Rohini Sharma, Consultant Medical Oncologist, Imperial College London
John Symons, NCRI Consumer Forum member
Juan Valle, Christie NHS Foundation Trust
Harpeet Wasan, Oncologist, Imperial College Healthcare NHS Trust – St Mary’s Hospital
The neuroendocrine workstream, chaired by Dr Alan Anthoney, develops research into cancer of neuroendocrine cells, cells that release hormones into the bloodstream.
Members:
Alan Anthoney, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary (subgroup chair)
Cathy Bouvier, NET Patient Foundation
Martyn Caplin, University College London (UCL)
Daniel Cuthbertson, University of Liverpool
Lindsey Devlin, NET Patient Foundation
Andrea Frilling, Imperial College London
Ashley Grossman, Queen Mary University of London
Prakash Manoharan, Christie NHS Foundation Trust
Was Mansoor, Consultant in Medical Oncology, Christie NHS Foundation Trust
Mairead Mcnamara, Honorary Consultant, Christie NHS Foundation Trust
Alia Munir, Sheffield Teaching Hospitals NHS Foundation Trust
Neil Pearce, University Hospital Southampton NHS Foundation Trust
John Ramage, Hampshire Hospitals NHS Foundation Trust
Debashis Sarker, King’s College London (KCL)
Maia Sissons
Denis Talbot, Professor of Cancer Medicine, King’s College London (KCL)
Christina Thirlwell, King’s College London (KCL)
Jon Wadsley, Consultant Clinical Oncologist, Sheffield Teaching Hospitals NHS Foundation Trust
The oesophagogastric workstream, chaired by Dr Christopher Peters, develops research into cancer of the oesophagus and the stomach.
Members:
Christopher Peters, Clinical Senior Lecturer & Consultant Upper GI Surgeon, Imperial College London (subgroup chair)
William Allum, Royal Marsden NHS Foundation Trust
Jane Blazeby, University of Bristol
Thomas Crosby, Clinical Director and Consultant Clinical Oncologist, Velindre Cancer Centre
David Cunningham, Consultant Medical Oncologist, Head of the Gastrointestinal and Lymphoma Unit and Director of Clinical Research, Royal Marsden NHS Foundation Trust
Jeff Evans, Director of the Institute of Cancer Sciences, Beatson West of Scotland Cancer Centre
Rebecca Fitzgerald, MRC Programme Leader, Medical Research Council (MRC) – Cancer Unit Cambridge
Hugo Ford, Addenbrooke’s Hospital NHS Foundation Trust
Heike Grabsch, Clinical Lecturer in Pathology, University of Leeds
Michael Griffin, Honourary Clinical Professor of Gastrointestinal Surgery, Newcastle University
Janusz Jankowski, Sherwood Forest Hospitals NHS Foundation Trust
Christopher Jones, Wellcome Trust Clinical Research Fellow; Honorary Specialty Registrar in Clinical Oncology, University of Leeds
Ruth Langley, Oncology and Clinical Trials, University College London (UCL)
Leena Mukherjee, Yeovil District Hospital NHS Foundation Trust
Somnath Mukherjee, Consultant Clinical Oncologist, Cancer Research UK (CRUK) Oxford – Medical Research Council (MRC), Oxford Institute for Radiation Oncology
Shaun Preston, King’s College London (KCL)
Elizabeth Smyth, Clinical Research Fellow/ Consultant, Royal Marsden NHS Foundation Trust
Anne Thomas, Medical Oncologist, University Hospitals of Leicester NHS Trust
Tim Underwood, Professor of GI Surgery and Clinical Scientist, University of Southampton
The pancreatic workstream, chaired by Dr Pippa Corrie, develops research into cancer of the pancreas.
Members:
Pippa Corrie, Consultant medical oncologist, Addenbrooke’s Hospital NHS Foundation Trust (subgroup chair)
Thankamma Ajithkumar, Consultant Clinical Oncologist, Cambridge University Hospitals NHS Foundation Trust
Bristi Basu, Medical Oncologist, Academic Consultant in Experimental Cancer Therapeutics, University of Cambridge
Andrew Biankin, Director, University of Glasgow
John Bridgewater, Professor in medical oncology, UCL Cancer Institute
David Chang, Clinical Senior Lecturer in Surgery, Wolfson Wohl Cancer Research Centre, University of Glasgow
Jeff Evans, Director of the Institute of Cancer Sciences, Beatson West of Scotland Cancer Centre
Paula Ghaneh, University of Liverpool
Lesley Goodburn, Consumer Rep, National Cancer Research Institute (NCRI)
Richard Jackson
Nigel Jamieson, University of Glasgow
Hemant Kocher, Senior Lecturer & Consultant Surgeon, Barts and The London School of Medicine and Dentistry
Chris Macdonald, Head of Research, Pancreatic Cancer UK
Somnath Mukherjee, Consultant Clinical Oncologist, Cancer Research UK (CRUK) Oxford – Medical Research Council (MRC), Oxford Institute for Radiation Oncology
Eric O’Neill, CRUK/MRC Oxford Institute- Cell & Molecular Oncology (Onset & Therapy), University of Oxford
Daniel Palmer, University of Liverpool
Stephen Pereira, University College London (UCL)
David Propper, Consultant, Barts Health NHS Trust
Ganesh Radhakrishna, Consultant Clinical Oncologist -Gastrointestinal, Pancreatic, Oesophageal and hepaticopancreaticobiliary (HPB) cancers, Royal College of Radiologists
Keith Roberts, Queen Elizabeth Hospital Birmingham
Shivan Sivakumar, Academic Clinical Lecturer/ Honorary Speciality Registrar in Medical Oncology, University of Oxford
Juan Valle, Christie NHS Foundation Trust
Newton Wong, Consultant, University of Bristol